Crestwood Advisors Group LLC Sells 7,280 Shares of CME Group Inc. $CME

Key Points

• Crestwood Advisors reduced its stake in CME Group by 4.3%, selling 7,280 shares and leaving 163,600 shares valued at about $44.68 million.
• CME beat quarterly expectations with $3.36 EPS versus a $3.11 estimate and $1.88 billion in revenue (up 14.5% YoY), and declared a $1.30 quarterly dividend (annualized $5.20, ~1.8% yield).
• CME is expanding product offerings—including a planned June 1 launch of CFTC‑regulated Bitcoin Volatility futures, reported plans for physically settled uranium futures, first block trades in AVAX/SUI futures, and a new U.S. Dollar RepoFunds Rate benchmark—moves that could diversify revenue and draw institutional flows.

Crestwood Advisors Group LLC reduced its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 163,600 shares of the financial services provider's stock after selling 7,280 shares during the period. Crestwood Advisors Group LLC's holdings in CME Group were worth $44,676,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of CME Group by 1.7% in the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider's stock worth $9,802,366,000 after acquiring an additional 588,509 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of CME Group by 2.8% in the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider's stock worth $1,300,450,000 after acquiring an additional 130,848 shares during the period. Sanders Capital LLC bought a new position in shares of CME Group in the third quarter worth $1,006,932,000. Franklin Resources Inc. boosted its holdings in shares of CME Group by 0.6% in the third quarter. Franklin Resources Inc. now owns 3,381,133 shares of the financial services provider's stock worth $913,548,000 after acquiring an additional 20,213 shares during the period. Finally, Invesco Ltd. boosted its holdings in shares of CME Group by 23.0% in the third quarter. Invesco Ltd. now owns 2,830,323 shares of the financial services provider's stock worth $764,725,000 after acquiring an additional 528,358 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Price Performance

NASDAQ:CME opened at $286.85 on Friday. The firm has a market capitalization of $103.94 billion, a price-to-earnings ratio of 24.48, a P/E/G ratio of 3.49 and a beta of 0.23. CME Group Inc. has a 52-week low of $257.17 and a 52-week high of $329.16. The stock has a fifty day moving average of $301.50 and a 200 day moving average of $287.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm's quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter last year, the company earned $2.80 earnings per share. On average, research analysts expect that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 1.8%. CME Group's dividend payout ratio (DPR) is currently 44.37%.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Declared a quarterly dividend of $1.30 per share (payable June 25; record/ex‑div June 9) — supports shareholder income and signals confidence in cash flow. CME Group Declares Quarterly Dividend
• Positive Sentiment: Sources say CME plans to launch a physically settled uranium futures contract — could attract institutional flows into a thin, opaque market and create a new revenue stream. CME seeks to revive uranium trading with physical futures launch, sources say
• Positive Sentiment: Announced June 1 planned launch of CFTC‑regulated Bitcoin Volatility futures (settle to CME CF Bitcoin Volatility Index) — provides institutional hedging products and diversifies crypto-related revenue if approved. CME Group to Debut Regulated Bitcoin Volatility Futures
• Positive Sentiment: First block trades executed in new Avalanche (AVAX) and Sui (SUI) futures — early institutional uptake of recent product launches. CME Group Announces First Trades of New Avalanche and Sui Cryptocurrency Futures
• Positive Sentiment: Launched the U.S. Dollar RepoFunds Rate (RFR USD) benchmark — expands data/benchmark services and strengthens ties with fixed‑income and repo market participants. CME Group Launches New Benchmark to Track Overnight Funding Costs
• Neutral Sentiment: Bitcoin price volatility: reports show BTC pulled back from highs (~$82.7k to ~$80k) — affects crypto futures volumes and short-term trading activity at CME but direction for volumes is ambiguous. Bitcoin slips back to $80,000 after reaching $82,700 on US-Iran deal optimism; $242 million short squeeze fueled rally
• Negative Sentiment: Stock weakness partly reflects near‑term profit-taking and positioning ahead of the crypto-volatility futures debut; some coverage noted the share dip tied to that launch. CME Group (CME) Stock Dips Ahead of Bitcoin Volatility Futures Debut in June

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the sale, the general counsel owned 7,192 shares of the company's stock, valued at approximately $2,397,597.04. This trade represents a 31.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director directly owned 24,999 shares of the company's stock, valued at approximately $7,647,194.10. This trade represents a 1.19% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 7,791 shares of company stock valued at $2,489,421. Company insiders own 0.30% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Royal Bank Of Canada raised their price target on CME Group from $295.00 to $302.00 and gave the stock a "sector perform" rating in a report on Thursday, February 5th. UBS Group reaffirmed a "neutral" rating and issued a $310.00 price target on shares of CME Group in a report on Friday, February 6th. Keefe, Bruyette & Woods began coverage on CME Group in a report on Wednesday, April 8th. They issued a "market perform" rating and a $305.00 price target for the company. Argus reissued a "hold" rating on shares of CME Group in a research note on Wednesday, March 4th. Finally, Weiss Ratings raised CME Group from a "buy (b+)" rating to a "buy (a-)" rating in a research note on Monday, March 2nd. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $305.29.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.